176 related articles for article (PubMed ID: 22801990)
21. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis.
Wong KK; Fig LM; Gross MD; Dwamena BA
Nucl Med Commun; 2015 Apr; 36(4):363-75. PubMed ID: 25642803
[TBL] [Abstract][Full Text] [Related]
22. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET.
Otto D; Boerner AR; Hofmann M; Brunkhorst T; Meyer GJ; Petrich T; Scheumann GF; Knapp WH
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1405-12. PubMed ID: 15278308
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of planar scintigraphy using ⁹⁹mTc-MIBI in patients with secondary hyperparathyroidism: a meta-analysis.
Caldarella C; Treglia G; Pontecorvi A; Giordano A
Ann Nucl Med; 2012 Dec; 26(10):794-803. PubMed ID: 22875577
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis.
Treglia G; Cocciolillo F; de Waure C; Di Nardo F; Gualano MR; Castaldi P; Rufini V; Giordano A
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1144-53. PubMed ID: 22358431
[TBL] [Abstract][Full Text] [Related]
25. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Gosnell JE; Shen WT; Duh QY; Allen IE; Vriens MR; de Keizer B; Pampaloni MH; Suh I
Langenbecks Arch Surg; 2016 Nov; 401(7):925-935. PubMed ID: 27086309
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.
Treglia G; Castaldi P; Rindi G; Giordano A; Rufini V
Endocrine; 2012 Aug; 42(1):80-7. PubMed ID: 22350660
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of computed tomography for parathyroid adenoma localization; a systematic review and meta-analysis.
Kluijfhout WP; Pasternak JD; Beninato T; Drake FT; Gosnell JE; Shen WT; Duh QY; Allen IE; Vriens MR; de Keizer B; Hope TA; Suh I
Eur J Radiol; 2017 Mar; 88():117-128. PubMed ID: 28189196
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
Caldarella C; Treglia G; Giordano A
Clin Breast Cancer; 2014 Aug; 14(4):241-8. PubMed ID: 24472718
[TBL] [Abstract][Full Text] [Related]
29. [Imaging of parathyroid adenomas with F‑18 choline PET-CT].
Schweighofer-Zwink G; Hehenwarter L; Rendl G; Rettenbacher L; Langsteger W; Beheshti M; Pirich C
Wien Med Wochenschr; 2019 Feb; 169(1-2):15-24. PubMed ID: 30264384
[TBL] [Abstract][Full Text] [Related]
30. (11)C-Methionine positron emission tomography-computed tomography in localization of methoxyisobutyl isonitrile negative ectopic parathyroid adenoma.
Seniaray N; Sharma H; Arbind A; Jaimini A; D'souza M; Saw S; Hazari PP; Mishra AK; Sharma R; Mondal A
Indian J Nucl Med; 2016; 31(1):49-51. PubMed ID: 26917896
[TBL] [Abstract][Full Text] [Related]
31. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
Quak E; Blanchard D; Houdu B; Le Roux Y; Ciappuccini R; Lireux B; de Raucourt D; Grellard JM; Licaj I; Bardet S; Reznik Y; Clarisse B; Aide N
Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):658-666. PubMed ID: 29270788
[TBL] [Abstract][Full Text] [Related]
32. Whole-Body
Sheikhbahaei S; Marcus CV; Fragomeni RS; Rowe SP; Javadi MS; Solnes LB
J Nucl Med; 2017 Jul; 58(7):1031-1036. PubMed ID: 27980049
[TBL] [Abstract][Full Text] [Related]
33. The role of F18-fluorocholine positron emission tomography/magnetic resonance imaging in localizing parathyroid adenomas.
Khafif A; Masalha M; Landsberg R; Domachevsky L; Bernstine H; Groshar D; Azoulay O; Lockman Y
Eur Arch Otorhinolaryngol; 2019 May; 276(5):1509-1516. PubMed ID: 30877424
[TBL] [Abstract][Full Text] [Related]
34. Tc-99m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-methionine PET/CT after previous thyroid surgery.
Schmidt MC; Kahraman D; Neumaier B; Ortmann M; Stippel D
Clin Nucl Med; 2011 Dec; 36(12):1153-5. PubMed ID: 22064100
[No Abstract] [Full Text] [Related]
35. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
[TBL] [Abstract][Full Text] [Related]
36. Comparative Diagnostic Performance of Ultrasonography and 99mTc-Sestamibi Scintigraphy for Parathyroid Adenoma in Primary Hyperparathyroidism; Systematic Review and Meta- Analysis.
Nafisi Moghadam R; Amlelshahbaz AP; Namiranian N; Sobhan-Ardekani M; Emami-Meybodi M; Dehghan A; Rahmanian M; Razavi-Ratki SK
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3195-3200. PubMed ID: 29281866
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of
Yomo S; Oguchi K
BMC Cancer; 2017 Nov; 17(1):713. PubMed ID: 29110648
[TBL] [Abstract][Full Text] [Related]
38. [11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery.
Cook GJ; Wong JC; Smellie WJ; Young AE; Maisey MN; Fogelman I
Eur J Endocrinol; 1998 Aug; 139(2):195-7. PubMed ID: 9724076
[TBL] [Abstract][Full Text] [Related]
39. Detection of glioma recurrence by ¹¹C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta-analysis.
Deng SM; Zhang B; Wu YW; Zhang W; Chen YY
Nucl Med Commun; 2013 Aug; 34(8):758-66. PubMed ID: 23670103
[TBL] [Abstract][Full Text] [Related]
40. [Scintigraphic demonstration of a parathyroid adenoma with 75Se-methionine].
Grebe SF
Med Klin; 1967 Apr; 62(17):672-4. PubMed ID: 5595336
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
